0001415889-13-001349.txt : 20130709
0001415889-13-001349.hdr.sgml : 20130709
20130709170011
ACCESSION NUMBER: 0001415889-13-001349
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130701
FILED AS OF DATE: 20130709
DATE AS OF CHANGE: 20130709
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Echo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001031927
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411649949
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 PENN CENTER
STREET 2: 1628 JFK BLVD, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 215-717-4100
MAIL ADDRESS:
STREET 1: 8 PENN CENTER
STREET 2: 1628 JFK BLVD, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
FORMER COMPANY:
FORMER CONFORMED NAME: SONTRA MEDICAL CORP
DATE OF NAME CHANGE: 20020702
FORMER COMPANY:
FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC/MN/
DATE OF NAME CHANGE: 20020701
FORMER COMPANY:
FORMER CONFORMED NAME: SONTRA MEDICAL CORP
DATE OF NAME CHANGE: 20020701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRIECO WILLIAM
CENTRAL INDEX KEY: 0001248557
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35218
FILM NUMBER: 13960175
MAIL ADDRESS:
STREET 1: 830 CRESCENT CENTRE DRIVE
STREET 2: SUITE 610
CITY: FRANKLIN
STATE: TN
ZIP: 37067
4/A
1
form4a-07092013_050702.xml
X0306
4/A
2013-07-01
2013-07-02
0001031927
Echo Therapeutics, Inc.
ECTE
0001248557
GRIECO WILLIAM
8 PENN CENTER
1628 JFK BLVD, SUITE 300
PHILADELPHIA
PA
19103
true
false
false
false
Common Stock
2013-07-01
4
A
0
400
0
A
23300
D
Nonqualified Stock Option (right to buy)
2.49
2013-07-01
4
A
0
1500
0
A
2014-07-01
2023-07-01
Common Stock
1500
3000
D
The shares vest on July 1, 2014, provided, however that all unvested Restricted Shares shall immediately vest upon the sale of or substantially all of the assets of the Company of all or substantially all of the outstanding capital stock of the Company in exchange for Liquid Proceeds. As used herein, "Liquid Proceeds" shall mean (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days; or (d) or a combination of cash and the foregoing securities.
This amendment to Form 4 is to properly reflect beneficial ownership following a 1 for 10 reverse stock split on June 7, 2013. The transaction reported on the Form 4 dated July 1, 2013 were accurate.
The Options vest on July 1, 2014; provided, however, that all unvested Options shall immediately vest upon the sale of all or substantially all of the assets of the Company or all or sustainably all of the outstanding capital stock of the Company in exchange for Liquid Proceeds.
/s/ Kimberly A. Burke, Attorney-in-Fact
2013-07-09